Cure Pharmaceutical Holding Corp. - FORM 8-K/A - EX-3.4 - CERTIFICATE OF AMENDMENT - December 13, 2016

Attached files

file filename
EX-99.3 - UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS - Cure Pharmaceutical Holding Corp.mkkn_ex993.htm
EX-99.2 - UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS - Cure Pharmaceutical Holding Corp.mkkn_ex992.htm
EX-10.4 - FORM OF WARRANT - Cure Pharmaceutical Holding Corp.mkkn_ex104.htm
8-K/A - FORM 8-KA - Cure Pharmaceutical Holding Corp.mkkn_8ka.htm

EXHIBIT 3.4

 

BARBARA K. CEGAVSKE

Secretary of State

202 North Carson Street

Carson City, Nevada 89701-4201

(775) 684-5708

Web site: www.nvsos.gov

 

Filed in the office of

Barbara K. Cegayske

Secretary of State

State of Nevada

 

Document Number

 

20160518990-91

Filing Date and Time

11/30/2016 8:53 AM

Entity Number

E0258352014-1

 

 

Certificate of Amendment

(PURSUANT TO NRS 78.385 AND 78.390)

 

 

USE BLACK INK ONLY - DO NOT HIGHLIGHT

 

ABOVE SPACE IS FOR OFFICE USE ONLY

 

Certificate of Amendment to Articles of Incorporation
For Nevada Profit Corporations

(Pursuant to NRS 78.385 and 78.390 After Issuance of Stock)

  

1. Name of corporation:

 

MAKKANOTTI GROUP CORP.

 

2. The articles have been amended as follows: (provide article numbers, it available)

 

The corporation’s name has been changed to: CURE Pharmaceutical Holding Corp.

 

3. The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation* have voted in favor of the amendment is: 72.05%

 

4. Effective date and time of filing: (optional) Date:

Time:

 

(must not be later than 90 days after the certificate is filed)

 

5. Signature: (required)

 

/s/ Michael Hlavsa                                                       

Signature of Officer

 

if any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, then the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a Majority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions on the voting power thereof.

 

IMPORTANT: Failure to include any of the above information and submit with the proper fees may cause this filing to be rejected.

Cure Pharmaceutical Holding Corp. Reports